Henderson Jane, Chief Financial Officer of an undisclosed company, has demonstrated a pronounced selling bias in recent insider transactions, with $1.7 million in total sales compared to just $21,027 in purchases across two companies—APGE and AKRO. The bulk of activity has centered on APGE, where Jane executed 16 sales between November 2025 and March 2026, including a $170,000 transaction on March 25, 2026, and a $306,816 sale on January 2, 2026. Earlier sales were smaller but frequent, such as a $60,000 disposal on November 11, 2025, and a $130,000 transaction three days later. The only recent buy was a modest $21,027 market purchase of AKRO shares on August 12, 2025, the same day Jane sold $142,371 worth of AKRO stock—suggesting a rebalancing rather than accumulation.
Notably, Jane’s APGE disposals accelerated in early 2026, with three sales totaling $119,602 on March 2 alone, following a $160,000 transaction in January. The pattern contrasts sharply with earlier activity involving AKRO, where Jane’s last non-derivative sale predates the APGE disposals by over a year. While derivative transactions (coded "D") for AKRO and CRGX appear in the filings, they reflect awards or holdings adjustments with no monetary value reported. The absence of any purchases since mid-2025 and the concentration of high-value sales in APGE stock underscore a clear directional shift toward reducing exposure, particularly in the first quarter of 2026.
AI-assisted summary